INNT
TOTAL INVALIDATION PROCESSED BY THE IB
03/19/2026
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Case type
Recorded events
Latest update
Classification
Trademark type
Nice classes
Filing date
Registration date
Expiration date
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Structured fields from the responsible authority and the official record.
Status date
Last transaction
Responsible office
Status code
Official register
Drawing code
Owner type
Owner location
Examiner
Current location
Mark description
The mark consists of the stacked wording "RELIEF THERAPEUTICS" with a stylized tree design partially set on top of the letter "R" in "RELIEF".
Holders
Representatives
Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C
Nice Classes
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and veterinary products, namely, prescription drugs for the treatment of diabetic complications, inflammatory diseases, pulmonary affections, neurological diseases, and metabolic diseases; diagnostic products for medical use, namely, diagnostic preparations and reagents for the diagnosis of diabetic complications, inflammatory diseases, pulmonary affections, neurological diseases, and metabolic diseases; medicinal preparations and substances, namely, protein supplements, peptides from synthetic sources or extracted from natural organisms for the treatment of pulmonary affections, diabetic complications, neuropathies, allergies, and inflammation, and small chemical molecules from synthetic or natural sources for the treatment of pulmonary affections, diabetic complications, neuropathies, allergies, and inflammation ; biochemical preparations for medical or veterinary use, namely, for the treatment of diabetic complications, inflammatory diseases, pulmonary affections, neurological diseases, and metabolic diseases; biological and chemical reagents for medical or veterinary use; biological preparations for medical use, namely, for the treatment of diabetic complications, inflammatory diseases, pulmonary affections, neurological diseases, and metabolic diseases; chemical preparations for medical use, namely, for the treatment of diabetic complications, inflammatory diseases, pulmonary affections, neurological diseases, and metabolic diseases; biotechnological preparations for medical use, namely, for the treatment of diabetic complications, inflammatory diseases, pulmonary affections, neurological diseases, and metabolic diseases; biotechnological products for medical use, namely, prescription drugs for the treatment of diabetic complications, inflammatory diseases, pulmonary affections, neurological diseases, and metabolic diseases; medical diagnostic products, namely, diagnostic preparations and reagents for the diagnosis of diabetic complications, inflammatory diseases, pulmonary affections, neurological diseases, and metabolic diseases; biomarkers for medicine, namely, diagnostic biomarker reagents for medical purposes
Class 35
Business consulting; project management services for others for business purposes; business consultancy services; compilation and management of computerized databases and central data files in the field of medicine; compilation of statistics; collection and systematization of data in a central file; business information, namely, provision of commercial information in the field of pharmaceutical products and provision of commercial information for consumers relating to medical and scientific research in the field of pharmaceutical products
Class 42
Scientific and technological services, namely, scientific and pharmaceutical research, testing the efficacy, safety and tolerability of pharmaceuticals, and pharmaceutical drug development as well as new product research and design relating thereto; industrial analysis and research services in the field of pharmaceuticals, medical diagnostic preparations, and biotechnology; scientific research and development and medical research and development in the field of pharmaceuticals, medical diagnostic preparations and biotechnology; research and development in the field of biotechnology; research in the fields of chemistry and biology; research in the field of biochemistry; scientific research for medical purposes; research and development in the field of diagnostic preparations; product development consulting; research and development of products; pharmaceutical research and development services; computer-aided scientific research, testing and analysis services in the field of pharmaceuticals, medical diagnostic preparations and biotechnology; conducting of scientific feasibility studies; scientific analyses in the field of pharmaceuticals, medical diagnostic preparations and biotechnology; scientific research, testing and analysis services in the field of pharmaceuticals, medical diagnostic preparations and biotechnology; services provided by consultants in the field of scientific and industrial research, namely, research and development of new therapeutic pharmaceutical preparations; preparation of reports relating to scientific research; providing scientific research information in the form of scientific reports; provision of information and data relating to scientific and technological research and development in the field of pharmaceuticals, medical diagnostic preparations and biotechnology; providing research information and results in the fields of biotechnology, science and medicine from an on-line searchable database; pharmaceutical drug development services; pharmaceutical research and development; scientific laboratory services; scientific research services for third parties in the field of biotechnology; design and development of computer hardware and software; development and research of products for third parties; consultancy services relating to biotechnology; analysis services, namely, consulting services in the fields of biotechnology, pharmacotherapy research and development, diagnostics, and pharmaceutical research and development; pharmaceutical and biological development and research services for third parties; clinical research in the field of treatment of diabetic complications, inflammatory diseases, pulmonary affections, neurological diseases, and metabolic diseases; evaluation of pharmaceutical products; research in the field of pharmaceutical products; laboratory research in the field of medicinal and analytical chemistry, biology, pharmacology and toxicology; clinical development services, namely, research and development of new therapeutic pharmaceutical preparations; none of the foregoing for clinical trials on safety and effectiveness of drugs, apremilast, drugs for Behçet's disease, or for providing medical and scientific research information in the field of clinical trials
History of USPTO decisions and trademark events.
58 publications found
TOTAL INVALIDATION PROCESSED BY THE IB
03/19/2026
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
03/04/2026
INVALIDATION PROCESSED
03/04/2026
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
09/17/2025
CANCELLED SECTION 71
01/17/2025
REGISTERED - SEC. 7 REQUEST ABANDONED
06/01/2024
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
07/03/2023
POST REGISTRATION ACTION MAILED - SEC. 7
08/24/2022
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/16/2022
CHANGE OF NAME/ADDRESS REC'D FROM IB
04/16/2022
TEAS SECTION 7 REQUEST RECEIVED
03/22/2022
NEW REPRESENTATIVE AT IB RECEIVED
02/18/2022
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/20/2022
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/20/2022
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
01/20/2022
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/20/2022
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/20/2022
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/20/2022
FINAL DECISION TRANSACTION PROCESSED BY IB
10/26/2018
FINAL DISPOSITION NOTICE SENT TO IB
10/05/2018
FINAL DISPOSITION PROCESSED
10/05/2018
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/03/2018
REGISTERED-PRINCIPAL REGISTER
07/03/2018
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
06/08/2018
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/23/2018
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
05/23/2018
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/17/2018
PUBLISHED FOR OPPOSITION
04/17/2018
NOTIFICATION PROCESSED BY IB
04/13/2018
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/28/2018
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/28/2018
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/28/2018
NEW REPRESENTATIVE AT IB RECEIVED
03/15/2018
APPROVED FOR PUB - PRINCIPAL REGISTER
03/15/2018
EXAMINER'S AMENDMENT ENTERED
02/22/2018
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/22/2018
EXAMINERS AMENDMENT E-MAILED
02/22/2018
EXAMINERS AMENDMENT -WRITTEN
02/22/2018
TEAS/EMAIL CORRESPONDENCE ENTERED
02/02/2018
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/01/2018
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/01/2018
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/01/2017
NON-FINAL ACTION E-MAILED
08/01/2017
NON-FINAL ACTION WRITTEN
08/01/2017
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/14/2017
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/14/2017
TEAS/EMAIL CORRESPONDENCE ENTERED
07/11/2017
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/10/2017
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/10/2017
REFUSAL PROCESSED BY IB
01/27/2017
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/10/2017
REFUSAL PROCESSED BY MPU
01/10/2017
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/29/2016
NON-FINAL ACTION WRITTEN
12/28/2016
APPLICATION FILING RECEIPT MAILED
12/27/2016
ASSIGNED TO EXAMINER
12/23/2016
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/23/2016
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/22/2016
Continuous trademark protection
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.